DBV Technologies S.A.

DBVTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$5.6M

▲ 35.8% YoY

Net Income

-$146.9M

▼ 29.0% YoY

EPS

$-1.05

▲ 10.3% YoY

Cash

$194.2M

▲ 498.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.